186 related articles for article (PubMed ID: 30556339)
1. Higher blood pressure predicts diabetes and enhances long-term risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty-three-year follow-up of the Daqing diabetes prevention study.
Li X; Wang J; Shen X; An Y; Gong Q; Li H; Zhang B; Shuai Y; Chen Y; Hu Y; Li G
J Diabetes; 2019 Jul; 11(7):593-598. PubMed ID: 30556339
[TBL] [Abstract][Full Text] [Related]
2. Hypertriglyceridaemia predicts subsequent long-term risk of cardiovascular events in Chinese adults: 23-year follow-up of the Daqing Diabetes Study.
Wang J; Shen X; He S; An Y; Gong Q; Li H; Zhang B; Shuai Y; Chen Y; Hu Y; Li G
Diabetes Metab Res Rev; 2019 Sep; 35(6):e3163. PubMed ID: 30939629
[TBL] [Abstract][Full Text] [Related]
3. [Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].
Chen Y; Wang J; An Y; Gong Q; He Y; Zhang B; Li H; Shuai Y; Tang X; Jiang Y; Hong J; Yang W; Hu Y; Li G
Zhonghua Nei Ke Za Zhi; 2015 Jan; 54(1):13-7. PubMed ID: 25877139
[TBL] [Abstract][Full Text] [Related]
4. Impaired glucose tolerance and future cardiovascular risk after coronary revascularization: a 10-year follow-up report.
Tsuchida K; Mitsuma W; Sato Y; Ozaki K; Soda S; Hatada K; Tanaka K; Hosaka Y; Imai S; Takahashi K; Matsubara T; Oda H
Acta Diabetol; 2020 Feb; 57(2):173-182. PubMed ID: 31375898
[TBL] [Abstract][Full Text] [Related]
5. Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study.
Kabootari M; Hasheminia M; Azizi F; Mirbolouk M; Hadaegh F
Cardiovasc Diabetol; 2020 Mar; 19(1):41. PubMed ID: 32228577
[TBL] [Abstract][Full Text] [Related]
6. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
[TBL] [Abstract][Full Text] [Related]
7. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
[TBL] [Abstract][Full Text] [Related]
8. Influence of improvement or worsening of glucose tolerance on risk of stroke in persons with impaired glucose tolerance.
Shen X; Zhang P; Wang J; An Y; Gregg EW; Zhang B; Li H; Gong Q; Chen Y; Shuai Y; Engelgau MM; Hu Y; Bennett PH; Li G
Int J Stroke; 2018 Dec; 13(9):941-948. PubMed ID: 29956594
[TBL] [Abstract][Full Text] [Related]
9. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.
Li G; Zhang P; Wang J; An Y; Gong Q; Gregg EW; Yang W; Zhang B; Shuai Y; Hong J; Engelgau MM; Li H; Roglic G; Hu Y; Bennett PH
Lancet Diabetes Endocrinol; 2014 Jun; 2(6):474-80. PubMed ID: 24731674
[TBL] [Abstract][Full Text] [Related]
11. Diabetes and cardiovascular events in hypertensive patients.
Alderman MH; Cohen H; Madhavan S
Hypertension; 1999 May; 33(5):1130-4. PubMed ID: 10334799
[TBL] [Abstract][Full Text] [Related]
12. Individual and Combined Cardiometabolic Morbidities and the Subsequent Risk of Cardiovascular Events in Chinese Adults.
Wang J; Wang Z; Guo F; Zhang Y; Ji H; Chen G; Wan Q; Yan L; Wang G; Qin Y; Luo Z; Tang X; Huo Y; Hu R; Ye Z; Shi L; Gao Z; Su Q; Mu Y; Zhao J; Chen L; Zeng T; Yu X; Li Q; Shen F; Chen L; Zhang Y; Wang Y; Deng H; Liu C; Wu S; Yang T; Li M; Xu Y; Xu M; Zhao Z; Wang T; Lu J; Bi Y; Wang W; Ning G; Zhao Y; Qin G
J Clin Endocrinol Metab; 2022 Jan; 107(1):e84-e94. PubMed ID: 34427675
[TBL] [Abstract][Full Text] [Related]
13. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
Gong Q; Zhang P; Wang J; Ma J; An Y; Chen Y; Zhang B; Feng X; Li H; Chen X; Cheng YJ; Gregg EW; Hu Y; Bennett PH; Li G;
Lancet Diabetes Endocrinol; 2019 Jun; 7(6):452-461. PubMed ID: 31036503
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular disease risk in diabetes patients aged 40 years old and above in China].
Li JX; Li Y; Liu FC; Chen JC; Cao J; Chen SF; Hu DS; Shen C; Huang JF; Lu XF; Gu DF
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Nov; 48(11):968-974. PubMed ID: 33210870
[No Abstract] [Full Text] [Related]
15. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.
Wang T; Lu J; Su Q; Chen Y; Bi Y; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Xu M; Xu Y; Zhao Z; Yan L; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Shi L; Ning G; Zhao J; Wang W;
JAMA Cardiol; 2019 Sep; 4(9):874-883. PubMed ID: 31365039
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of 1-hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes-related complications: A post hoc analysis of the 30-year follow-up of the Da Qing IGT and Diabetes Study.
Peng M; He S; Wang J; An Y; Qian X; Zhang B; Zhang L; Chen B; Yang Z; Li G; Gong Q;
Diabetes Obes Metab; 2024 Jun; 26(6):2329-2338. PubMed ID: 38488254
[TBL] [Abstract][Full Text] [Related]
17. Hypertension and hyperglycemia and the combination thereof enhances the incidence of chronic kidney disease (CKD) in middle-aged and older males.
Michishita R; Matsuda T; Kawakami S; Tanaka S; Kiyonaga A; Tanaka H; Morito N; Higaki Y
Clin Exp Hypertens; 2017; 39(7):645-654. PubMed ID: 28590145
[TBL] [Abstract][Full Text] [Related]
18. Impaired glucose tolerance is a risk factor for stroke in a Japanese sample--the Funagata study.
Oizumi T; Daimon M; Jimbu Y; Wada K; Kameda W; Susa S; Yamaguchi H; Ohnuma H; Tominaga M; Kato T
Metabolism; 2008 Mar; 57(3):333-8. PubMed ID: 18249204
[TBL] [Abstract][Full Text] [Related]
19. The Singapore impaired glucose tolerance follow-up study: does the ticking clock go backward as well as forward?
Wong MS; Gu K; Heng D; Chew SK; Chew LS; Tai ES
Diabetes Care; 2003 Nov; 26(11):3024-30. PubMed ID: 14578234
[TBL] [Abstract][Full Text] [Related]
20. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
Ratner R; Goldberg R; Haffner S; Marcovina S; Orchard T; Fowler S; Temprosa M;
Diabetes Care; 2005 Apr; 28(4):888-94. PubMed ID: 15793191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
